LEVOCARNITINE

Generic: LEVOCARNITINE

Rising Pharma HoldingsManufacturer
ORALRoute
LEVOCARNITINEActive Substance
2004-08-10Original Approval

LEVOCARNITINE is FDA application ANDA076851, sponsored by RISING. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Class III2026-04-16
Levocarnitine Injection, USP, 1 g/5 mL (200 mg/mL), 5 mL Single-Dose Vial, For intravenous use, Rx Only, American Regent

Labeling: Missing Label

Top Reported Reactions

1
SEIZURE
288 reports
2
OFF LABEL USE
252 reports
3
VOMITING
184 reports
4
DIARRHOEA
177 reports
5
DRUG INEFFECTIVE
160 reports
6
FATIGUE
147 reports
7
PYREXIA
145 reports
8
PNEUMONIA
140 reports
9
PRODUCT DOSE OMISSION ISSUE
110 reports
10
SOMNOLENCE
105 reports